|Bid||0.00 x 800|
|Ask||0.00 x 800|
|Day's Range||71.79 - 72.79|
|52 Week Range||61.95 - 115.40|
|Beta (3Y Monthly)||1.38|
|PE Ratio (TTM)||37.22|
|Earnings Date||Jul 22, 2019 - Jul 26, 2019|
|Forward Dividend & Yield||0.48 (0.77%)|
|1y Target Est||89.63|
What a difference strong leadership can make for a company, as shown by General Electric (NYSE:GE) stock. Larry Culp, who came on board as CEO in October 2018, had the unenviable task of leading the company's turnaround.But his moves has been decisive and strategic. More importantly, he has brought realism to the company. Then again, Culp demonstrated those abilities while he was the CEO of Danaher (NYSE:DHR), which generated standout results for shareholders during his tenure. * 6 Stocks Ready to Bounce on a Trade Deal Source: Shutterstock GE stock has done great during Culp's brief time with the company. Since December, the shares have gained 55%.InvestorPlace - Stock Market News, Stock Advice & Trading TipsBut turnarounds often take a long time. And that will certainly be the case with GE's efforts. There is still lots of heavy lifting to be done, and GE is facing some tough headwinds. In other words, investors should be cautious, as the easy gains of GE stock may be over.In fact, there are already signs of that. Keep in mind that GE stock has been in a persistent range of $9 to $11 since February.So what issues is GE facing? Let's take a look at three risks of investing in General Electric stock. Risk Facing GE Stock: GE's FinancialsOne of the biggest changes at GE has been Culp's transparency with Wall Street. To this end, he says that 2019 will be a "reset" year. But the fact is that GE has a tremendous amount of debt and contingent liabilities. Cumulatively, GE owes a staggering $107.5 billion. So for quite some time, Culp will be mostly focused on finding ways to generate cash. To help accomplish that goal, he's already agreed to sell GE's biopharma business to Danaher and divest its locomotive segment, which was acquired by WabTec (NYSE:WAB).But given that GE is cyclical and that the global economy appears to be slowing, GE could easily report negative earnings surprises in the months ahead. Risk Facing GE Stock: GE's Aviation BusinessThe aviation business has been positive for General Electric stock for some time. As seen at this week's Paris Air Show, the unit is snagging plenty of orders. Note that it recently signed its biggest deal ever, agreeing to sell $20 billion of engines to an India-based airline.But unfortunately, the aviation business is still facing headwinds. For example, Boeing's (NYSE:BA) 777X widebody jet will not meet its deadline because of a problem caused by GE's engines. The problem is likely temporary, but it's still worrisome and will cause a meaningful amount of GE's revenue to be delayed.It's far from clear what will happen with the 737 MAX, which has been grounded because of two crashes. But again, this means loss of momentum for GE's engine business. Risk Facing GE Stock: GE's Power BusinessThe Power Business, which accounts for roughly 20% of GE's overall revenues, continues to be a problem for the company. The competitive environment of the sector is intense, demand for Power's products has been sluggish for some time, and it's been accused of being less than 100% forthright about its results. There are also signs that Chinese companies may make inroads in this industry.Here's what JPMorgan analyst Stephen Tusa has said about the situation: "We believe a full accounting of the situation with a closer look at the data, even a rudimentary review, supports our view that GE is indeed losing market share…"Keep in mind that Tusa was able to predict the implosion of GE stock. Consider that he currently has a $5 price target on the shares, implying a drop of more than 50% from their current levels.Tom Taulli is the author of the upcoming book, Artificial Intelligence Basics: A Non-Technical Introduction. Follow him on Twitter at @ttaulli. As of this writing, he did not hold a position in any of the aforementioned securities. More From InvestorPlace * 4 Top American Penny Pot Stocks (Buy Before June 21) * 7 Blue-Chip Stocks to Buy for a Noisy Market * 5 Strong Buy Biotech Stocks for the Second Half * 6 Stocks Ready to Bounce on a Trade Deal Compare Brokers The post 3 Reasons GE Stock May Stall Out appeared first on InvestorPlace.
Investing in hedge funds can bring large profits, but it’s not for everybody, since hedge funds are available only for high-net-worth individuals. They generate significant returns for investors to justify their large fees and they allocate a lot of time and employ a complex analysis to determine the best stocks to invest in. A particularly […]
With all due respect to the analyst community, please stop handicapping General Electric (NYSE:GE) as if it's possible to know where the company will be a year from now. Likewise to investors, be wary of treating GE stock as if it reasonably compares to peers such as Honeywell International (NYSE:HON) or Danaher (NYSE:DHR).Source: Shutterstock GE is, more than anything else right now, an enigma… an idea. Choosing not to acknowledge it as such could prove frustrating.That's not intended as an insult to parties on either side of the capital-markets table, to be clear. The aforementioned pitfalls are easy to stumble into; I've stumbled into both traps more than once myself.InvestorPlace - Stock Market News, Stock Advice & Trading Tips * 7 High-Quality Cheap Stocks to Buy With $10 But, as a guy who's been in the investing business for 20 years now (with the gray and thinning hair to prove it) I can say I've seen, heard, and done it all, most of it twice.That includes the current General Electric story and all of its nuances; same story, different name. And, the fact of the matter is, nobody has a clue General Electric is really going. They're all guessing. We're all guessing.There is one thing I am confident of though. That is, if GE stock can clear one key technical hurdle, all that rhetoric is going to turn bullish in a hurry, driving what could be a decent bullish swing trade that may well flag the long-awaited, bigger turnaround. A Closer Look at GEIt's not a reality too many in the financial media and investment-advice business care to concede, but sometimes, our best guesses still aren't all that good.It's a rarity, to be fair. People paid to pontificate tend to have a rather firm grip on things that are taking shape with the economy, the market and with individual companies.This isn't one of those times though. General Electric has thrown a lot of people for a loop.But, at least the professionals at this dance have to chime in with something on the company.Reality: The sale of General Electric's assets like its locomotive arm to WabTec (NYSE:WAB) and the rumored liquidation of its aviation finance arm are seemingly steps in the right direction. GE needs cash to shore up liquidity problems, and selling assets is the quickest way to raise liability-free cash. Bear in mind, however, the company is selling revenue-bearing and in many cases profit-driving assets.Some say there's more upside to paring itself down, but others are less convinced divestitures are the right move given the company's cash-flow challenges.Its Power arm is in trouble too. Let's not pretend like that's not at least partially the result of persistently tepid oil and gas prices though, admittedly underscored by a lack of product development.The former remains entirely out of the company's control, no matter how well General Electric regroups its power business from the inside.The biggest X factor of all though is the unknowable. Right now, there are simply an overwhelming number of unknowables muddling up a clear view of the company's fiscal strength.Perhaps more so than any other outfit seen in the modern market era, General Electric is a moving target… multiple moving targets, in fact. Nobody really knows what lies ahead, even if their thesis seem rock-solid and well-polished. Looking Ahead for GE StockThat's not to suggest GE stock has to be avoided. Indeed, General Electric has the potential to be very rewarding for the right kind of trader.The key is simply understanding that the chart of GE stock right now is driving opinions of the stock as much as it's being driven by them.To that end, we're all lucky in the sense that investors have collectively, unconsciously drawn their line in the sand. It's $10.48, where GE stock has peaked a couple of times since March.It's working on another test of that technical ceiling right now, but is starting that effort with the benefit of its first streak of higher lows since 2016.Notice GE shares have also crossed back above the 200-day moving average line, plotted in white, and this time seem a little more willing to stay here.Zooming out to the weekly chart we can see this week's strength presses against the line that's capped all the key highs going back to May of last year.Clearly there's more work to be done. But, if General Electric shares can move above its recent ceilings, it becomes much easier to justify buying.It also becomes much easier to justify upgrades; don't think for a minute analysts' handling of the turnaround story aren't being scrutinized more than they normally might for other names.Just wait and watch. The Final WordI'm all too aware that penning these kinds of ideas is maddening to a whole slew of people… professionals as well as amateurs. The notion that a chart can lead to opinion changes rather than the other way around is often dismissed. And, there was a point in time, years ago, when such an idea should have been dismissed.The market's changed though. Fundamentals don't matter nearly as much as stories do, assuming that fundamentals mean anything anymore. In the case of General Electric right now, they may not.Whatever the case, don't kid yourself about what GE stock is here. You're not making a bet on the company by buying it now, or after any cross above $10.48.You're making a bet on how the masses are going to feel about GE at some point in the foreseeable future. Indirectly, you're betting on how analysts are going to change their opinions when they absolutely have to.As of this writing, James Brumley did not hold a position in any of the aforementioned securities. You can learn more about James at his site, jamesbrumley.com, or follow him on Twitter, at @jbrumley. More From InvestorPlace * 4 Top American Penny Pot Stocks (Buy Before June 21) * 7 High-Quality Cheap Stocks to Buy With $10 * 7 U.S. Stocks to Buy With Limited Trade War Exposure * 6 Growth Stocks That Could Be the Next Big Thing Compare Brokers The post The Problem Is, GE Stock Is Just Unknowable Right Now appeared first on InvestorPlace.
After a shaky May for markets following the trade war drama between the US and China, TD Ameritrade's IMX, a monthly review of investor behavior based on its client's portfolio activity, reported a modest 7 percent increase from April's score of 4.61. This is the highest IMX score in six months. Despite increased trade tensions, investors increased their overall exposure to equities throughout the month.
TD Ameritrade clients increased exposure to equity markets during the May IMX period, increasing the IMX score by 6.94% to 4.93, up 0.32 from the previous period. TD Ameritrade clients were net buyers ...
Westinghouse Air Brake Technologies Corp NYSE:WABView full report here! Summary * ETFs holding this stock are seeing positive inflows but are weakening * Bearish sentiment is high * Economic output in this company's sector is contracting Bearish sentimentShort interest | NegativeShort interest is high for WAB with between 15 and 20% of shares on loan. This means that investors who seek to profit from falling equity prices are currently targeting WAB. However, the last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment. Money flowETF/Index ownership | NegativeETF activity is negative and may be weakening. The net inflows of $1.45 billion over the last one-month into ETFs that hold WAB are among the lowest of the last year and appear to be slowing. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managersâ€™ Index (PMI) data, output in the Industrialsis falling. The rate of decline is very significant relative to the trend shown over the past year, and is accelerating. The rate of contraction may ease in the coming months, however. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to email@example.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
Wabtec Corporation announced today that its Board of Directors declared a regular quarterly common dividend of 12 cents per share, payable on August 23, 2019 to holders of record as of August 9, 2019.
After a white-hot start to 2019, it has been a wild ride for investors. As the war of words has progressed in the trade battle between China and the U.S., price volatility has been on the rise. Investors tend to shy away from volatility, which is a word that generally is only mentioned when prices are moving lower. In fact, the CBOE Volatility Index (VIX) is often referred to as the "fear gauge."However, seasoned investors realize that volatility can be your friend. "When you put it all together, this is a healthy time to come into the market for the long term," said Thorne Perkin, president of Papamarkou Wellner Asset Management, to CNBC on May 16. "We always look at these pullbacks as buying opportunities for the long term." * 7 Stocks to Sell Amid an Escalating Trade War In short, attractive investments are out there if you're willing to dig a little deeper. Here are seven stocks primed to take off. I sourced these companies by looking for stocks with a bullish "strong buy" Street consensus on TipRanks. That's based on all ratings received in the last three months. Plus I also ensured that the average analyst price target indicates attractive upside potential from current levels.InvestorPlace - Stock Market News, Stock Advice & Trading TipsWith that in mind, let's dive in now: Stocks to Buy: Health Insurance Innovations (HIIQ)Health Insurance Innovations (NASDAQ:HIIQ) is a leading developer of affordable, web-based individual health insurance plans. According to the Street, this is a company with huge upside potential."We believe that HIIQ is well-positioned to benefit from increasing demand for short-term medical products. We expect top-line growth of 24% in 2019 and 3-15% annual top-line growth for the rest of our explicit forecast" reveals Cantor Fitzgerald's Steven Halper. "HIIQ shares remain inexpensive, in our opinion, as they trade below our DCF-based price target of $75."Given the current sub-$25 share price, this translates into 200% upside potential! And before you dismiss this, note that Halper ranks No. 129 out of over 5,000 analysts for his strong stock picking skills.The analyst adds "We reiterate our view that concerns regarding HIIQ's exposure to FTC lawsuit against Simple Health are entirely overblown." This is regarding the dispute between the FTC and one of the company's former distributors, Simple Health. However a recent disclosure shows that HIIQ is not a defendant or party in the case and is in regular dialogue with the FTC. "This disclosure, in our view, should put to bed any lingering concerns regarding HIIQ's exposure to Simple Health" says Halper.Raymond James analyst Randy Binner echoes this message -- he believes the resolution of the matter will be positive for shares. Indeed, HIIQ boasts seven recent buy ratings from the Street. Its average analyst price target stands at $65 (160% upside potential). Interested in Health Insurance stock? Get the HIIQ Stock Research Report. Wabtec Corp (WAB)Welcome to our second pick, Wabtec Corporation (NYSE:WAB) -- an under-the-radar stock poised to outperform. Wabtec is one of the world's largest providers of tech components and services for the rail industry. It has products on virtually all U.S. locomotives, freight cars and passenger transit vehicles, as well as in more than 100 other countries.That means the stock is perfectly positioned to benefit from the accelerating growth of global transit rail markets -- especially following the transformative $11 billion GE Transportation merger."We see Wabtec as the number one rail automation play" cheers Cowen & Co's Matt Elkott. "WAB pays a dividend and is well positioned for organic and external growth. This deep value, income and growth trifecta should appeal to new long-term investors" cheers Elkott. * 7 Stocks to Buy for June He reiterated his WAB buy rating on May 22 with a $92 price target. That indicates sizable upside potential of over 40%. "WAB now trades at ~11x adjusted 2020E EPS, almost half the multiple of its closest comp KBX, a discount unwarranted by fundamentals" the analyst tells investors. Note that the Street shares this perspective. Although only three analysts cover WAB, all three rate the stock a "buy." Get the WAB Stock Research Report. Amazon (AMZN)This list also includes one of my favorite FAANG stocks -- Amazon (NASDAQ:AMZN). Amazon has everything going for it right now. Despite a 7% pullback in the last month, shares are still up 23% so far this year. And plenty of upside potential lies ahead. According to Piper Jaffray analyst Michael Olson, AMZN stock is on track for some impressive share gains. Even better, these gains are possible without much "extra' work from Amazon:"We believe AMZN shares will reach $3,000 by sometime between mid-'21 and mid-'22 or within 24-36 months," Olson calculated. This equates to a rally of about 65% from current levels. "We have a high degree of confidence that AMZN shares can reach this level with no major acquisitions or other significant changes to the business.""Adjusting for the value of the AWS segment and Advertising (within "Other"), the company's core retail segment is trading at a level that implies that business is valued below a traditional brick & mortar multiple of sales," he explained. A potential Amazon Web Services spin off would also highlight the "relatively low valuation of the other segments," the Top 100 analyst added.With 35 "buy" ratings in the last three months, Amazon has a full show of support from the Street right now. Meanwhile the average analyst price target of $2,230 indicates upside potential of 23%. Get the AMZN Stock Research Report. Intercept Pharma (ICPT)Biopharma Intercept Pharmaceuticals Inc (NASDAQ:ICPT) is one of the best-rated healthcare stocks right now, according to TipRanks. This is a company developing chronic liver disease treatments using its special bile acid chemistry. Its lead product candidate, obeticholic acid, or OCA, is a bile acid analog already approved for primary biliary cirrhosis (PBC).Crucially, the drug is now also in development for non-alcoholic steatohepatitis (NASH) and primary sclerosing cholangitis (PSC). According to Reports and Data, the global NASH market is expected to reach $13.38 billion by 2026. In short, we are looking at a very lucrative opportunity for drug companies.RBC Capital's Brian Abrahams has a buy rating on ICPT with a $143 price target (69% upside potential). Abrahams calculates the current PBC indication has $400M potential, but that approval of OCA for NASH could create a significant additional $2.5 billion-plus opportunity. "We believe that OCA's efficacy profile is supportive of approval" says the analyst."With stable growth in PBC, a high likelihood of first-to-market approval in large NASH market with meaningful effect on fibrosis, and enthusiasm among physicians, we believe shares currently underappreciate OCA's peak revenue potential" the analyst writes. * 7 Utility Stocks to Trust for Retirement What's more, he draws parallels between Intercept and InterMune, which Roche ultimately acquired for $8.3 billion. "While we acknowledge it is not a perfect apples-to-apples comparison, we believe the similarities do further highlight the significant valuation disconnect for ICPT" says Abrahams. Out of the 11 analysts polled, 10 rate ICPT a "buy." And their $165 average analyst price target suggests even greater upside potential of 96%. Get the ICPT Stock Research Report. Aphria (APHA)If you are looking for a marijuana stock with plenty of growth potential, look no further. Low-cost Canadian cannabis producer Aphria (NYSE:APHA) has only buy ratings from the Street. Their average analyst price target of $11 indicates shares can spike 60% from current levels. That's on top of the 11% growth already experienced year-to-date.Jefferies' analyst Owen Bennett has just initiated coverage of APHA stock. His bullish review of the stock sent shares soaring 8%. "On our strategic scorecard Aphria scores highly, and third overall behind only Canopy and Aurora," Bennett told investors. "Despite its strong global outlook, its valuation is the cheapest across our space, with allegations around inflated assets/insider deals weighing."The company suffered a disastrous 2018, featuring a hostile takeover attempt, the exit of its CEO and allegations from a short-seller that insiders profited from acquiring international businesses at highly inflated prices. However a special board committee found that the price paid for businesses in Latin America was acceptable. And with chairman Irwin Simon now acting as interim CEO, this cannabis stock is ready to rebound. "With these issues now seemingly cleared up, as the company continues to execute, and with likely positive developments on U.S. optionality/Canadian derivatives, we see significant re-rating" says Bennett.Intriguingly, the analyst also adds: "In Canadian derivatives we think there's a good possibility of a vapor partnership with Pax." Bennett has an $11.14 price target on APHA stock. Get the APHA Stock Research Report. Alibaba (BABA)Chinese e-commerce giant Alibaba (NYSE:BABA) has taken a bit of a hit recently. Shares are down 19% over the last month. But that just means we are looking at more compelling upside potential of 40%. That's based on the stock's 16 recent back-to-back buy ratings and bullish $217 average price target.Five-star Stifel Nicolaus analyst Scott Devitt has just reiterated his BABA buy rating. But even more promisingly, he has now added Alibaba to the firm's elite 'Select List' of favorite stock ideas. "We continue to like Alibaba as a leading global eCommerce company that holds a dominant market share in China online shopping and operates an efficient, commission/ advertising model in its core marketplace businesses, Tmall and Taobao" explains Devitt. He has a $220 price target on shares (45% upside potential).For investors concerned about U.S.-China tensions, you can breathe easy. According to Devitt, Alibaba has "limited exposure" to the ongoing trade war. Luckily, cross-border business between the U.S. and China is a relatively small component of total company revenue. And long-term trends like the growing middle class and an increasingly services-based economy are more important to Alibaba's growth trajectory, says the analyst. * 5 Safe Stocks to Buy This Summer Additionally, as Joe Tsai pointed out, Alibaba is on the right side of the issues surrounding the trade conflict, such as China becoming more open to foreign businesses, intellectual property protection and the shift towards digitization. Get the BABA Stock Research Report. Verint (VRNT)Verint Systems (NASDAQ:VRNT) is a software stock specializing in customer engagement technology. Unfortunately for Verint, a bear report has just sent shares spiraling 8%. Bad news for Verint, but good news for us. Bear in mind, on a year-to-date basis, shares are still up 34%.Short seller Spruce Point Capital claims the company is using M&A to hide low organic growth. Verint has already released its own counter-statement saying "We stand by … the recently provided long-term organic growth targets for revenue and margin expansion."Analysts are providing further support to VRNT's statement. This is a company with 100% buy ratings from top-performing analysts. That means no hold or sell ratings in the last three months. One of the analysts is Wedbush's Daniel Ives. He calls the selloff "pure noise" and writes "we strongly disagree with all the issues raised [in the report].""As we have seen the company emerge from the post Comverse dark days into a $1 billion+ revenue thriving company today and successfully beating the Street's forecasts for the last 6-8 quarters, it is NOT a surprise that now some of the bears will come out of hibernation mode and try to poke holes in the company's emerging success story" Ives tells investors.He believes we now have a "golden buying opportunity" to own this secular growth name that "is still in the early innings of penetrating its installed base with a holistic cloud strategy." According to Ives, another guidance raise for the year is likely. Get the VRNT Stock Research Report.TipRanks.com offers exclusive insights for investors by focusing on the moves of experts. See what the experts are saying about your stocks now at TipRanks.com. As of this writing, Harriet Lefton did not hold a position in any of the aforementioned securities. More From InvestorPlace * 4 Top American Penny Pot Stocks (Buy Before June 21) * 7 Stocks to Sell Amid an Escalating Trade War * 5 REITs to Buy While They're Dirt Cheap * The Only 3 Marijuana Stocks You Need to Own Compare Brokers The post 7 Stocks to Buy for Monster Growth appeared first on InvestorPlace.
Wabtec (WAB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
MSA Safety Inc. has snapped up Wabtec Corp.’s director of corporate development as the Cranberry-based developer and supplier of safety products accelerates acquisitions. Christopher Hepler, responsible for the rail manufacturer’s global M&A activities since 2015, is now MSA’s executive director of corporate development.
The two parties are still at odds over contract negotiations. The expiration date of the interim agreement looms close.
Wabtec shareholders today elected two directors and approved other company proposals at its annual meeting in Pittsburgh. Directors elected were: William E. Kassling and Albert J.
Fairfield, CT, based Investment company General Electric Co buys Westinghouse Air Brake Technologies Corp, Neuronetics Inc during the 3-months ended 2019Q1, according to the most recent filings of the ...
On Wednesday, the company announced a strategic move in that direction with an investment in General Electric Additive’s H2 binder jet printer capabilities. “Additive technology is going to transform our business and products. “Our team can reimagine how to approach designing and testing products.” The company’s first H2 machine is currently in GE’s Additive Laboratory in Cincinnati, but will be moved to Wabtec’s new Grove City engine plant by the end of the year.
Sydney, Nsw, C3, based Investment company VGI PARTNERS PTY Ltd buys Westinghouse Air Brake Technologies Corp, sells Zillow Group Inc during the 3-months ended 2019Q1, according to the most recent filings ...
A number of rail equipment lessors and manufacturers have been merging and consolidating in recent months as a way to leverage themselves against marketplace changes brought about by precision scheduled railroading (PSR), an operational model that seeks to cut costs. Among them, railcar manufacturer Greenbrier (NYSE: GBX) acquired the manufacturing segment of American Railcar Industries in April as a way for Greenbrier to solidify its role as a supplier of covered hoppers and tank cars. In February 2019, Wabtec's (NYSE: WAB) merged with GE Transportation to ramp up its market presence as a rail component manufacturer specializing in automation and locomotive upgrades, according to Matt Elkott, an analyst with investment firm Cowen.